AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2011
Jan 7, 2011
35599_dirs_2011-01-06_62593f2b-76bd-4cb3-a67c-69bab914138f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ADHEREX TECHNOLOGIES INC (AHX)
CIK: 0001211583
Period of Report: 2010-06-24
Reporting Person: Lieberman David B. (Director)
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20